ImmunityBio, Inc. Annual Return On Assets in % from 2016 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
ImmunityBio, Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2024.
  • ImmunityBio, Inc. Return On Assets for the quarter ending December 31, 2024 was -104 %, a 30% increase year-over-year.
  • ImmunityBio, Inc. annual Return On Assets for 2024 was -104 %, a 30% increase from 2023.
  • ImmunityBio, Inc. annual Return On Assets for 2023 was -148 %, a 26.7% decline from 2022.
  • ImmunityBio, Inc. annual Return On Assets for 2022 was -117 %, a 3.82% increase from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -104 +44.6 +30% Jan 1, 2024 Dec 31, 2024
2023 -148 -31.3 -26.7% Jan 1, 2023 Dec 31, 2023
2022 -117 +4.65 +3.82% Jan 1, 2022 Dec 31, 2022
2021 -122 +0.6 +0.49% Jan 1, 2021 Dec 31, 2021
2020 -122 -44.9 -57.8% Jan 1, 2020 Dec 31, 2020
2019 -77.5 -30.9 -66.2% Jan 1, 2019 Dec 31, 2019
2018 -46.7 -12.6 -37.1% Jan 1, 2018 Dec 31, 2018
2017 -34 +1.76 +4.92% Jan 1, 2017 Dec 31, 2017
2016 -35.8 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.